Canada - English - Health Canada

pfizer canada ulc - pentamidine isetionate - powder for solution - 300mg - pentamidine isetionate 300mg - miscellaneous antiprotozoals

Canada - English - Health Canada

marcan pharmaceuticals inc - pentamidine isetionate - powder for solution - 300mg - pentamidine isetionate 300mg - miscellaneous antiprotozoals

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sanofi - pentamidine isetionate - powder for solution for injection - 300mg

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - pentamidine isetionate -

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - pentamidine isetionate, quantity: 300 mg - injection, powder for - excipient ingredients: - pentamidine isethionate is indicated for intravenous administration in the treatment of the following conditions: . as an alternative first line treatment for pneumocystis carinii infection in aids patients; . as second line treatment for pneumocystis carinii infection in non-aids patients; . as second line treatment of leishmaniasis (visceral and cutaneous), except leishmania aethiopica where it may be used as first line treatment; . as second line treatment for trypanosomiasis (except for the trypanosomiasis rhodesiense strain due to lack of efficacy).

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - pentamidine isetionate, quantity: 300 mg - injection, powder for - excipient ingredients: - pentamidine isetionate for injection bp is a medicine used to treat infection in the lung (pneumonia)

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - pentamidine isetionate 300mg;   - powder for injection - 300 mg - active: pentamidine isetionate 300mg   - pneumonia due to pneumocystis jiroveci (carinii) occurring in debilitated or immunocompromised patients, e.g. in aids. pentamidine isethionate is particularly valuable for patients with a history of allergy to sulphonamides, or who have severe reactions, or a lack of response to treatment with co-trimoxazole in p. jiroveci (carinii) pneumonia. for aerosol administration via a nebuliser is indicated for the prevention of pneumocystis jiroveci (carinii) pneumonia in patients infected by the human immunodeficiency virus (hiv).

Australia - English - Department of Health (Therapeutic Goods Administration)

emcure pharmaceuticals pty ltd - pentamidine isetionate, quantity: 300 mg - injection, powder for - excipient ingredients: water for injections; nitrogen - pentamidine isethionate is indicated for intravenous administration in the treatment of the following conditions:,- as an alternative first line treatment for pneumocystis carinii infection in aids patients;,- as second line treatment for pneumocystis carinii infection in non-aids patients;,- as second line treatment of leishmaniasis (visceral and cutaneous), except leishmania aethiopica where it may be used as first line therapy;,- as second line treatment for trypanosomiasis (except for the trypanosomiasis rhodesiense strain due to lack of efficacy).

United States - English - NLM (National Library of Medicine)

seton pharmaceuticals - pentamidine isethionate (unii: v2p3k60da2) (pentamidine - unii:673lc5j4lq) - pentamidine isethionate 300 mg in 300 mg - pentamidine isethionate for injection is indicated for the treatment of pneumonia due to pneumocystis carinii. contraindicated in patients with a history of hypersensitivity to pentamidine isethionate.

Canada - English - Health Canada

david bull laboratories (pty) ltd. - pentamidine isetionate - powder for solution - 300mg - pentamidine isetionate 300mg - miscellaneous antiprotozoals